Grimes & Company’s EyePoint Inc EYPT Stock Holding History

Grimes & Company’s Portfolio EYPT Stock Details EYPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-9,850	Closed	-$153K	–	244
2019 Q4	$153K	Buy	+9,850	New	+$176K	0.01%	255

Other funds holding EYPT

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

EIM

Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Grimes & Company's EYPT Position: Q1 2020 in Review

Grimes & Company sold out of EyePoint Inc (EYPT) in Q1 2020, closing a stake of 9,850 shares — an estimated $153K sold.

Grimes & Company first reported a position in EYPT in Q4 2019 and held it in 1 quarter. The position peaked at $153K in Q4 2019. 66 funds tracked by Wall St. Rank hold EYPT as of Q1 2020.

Grimes & Company reported no remaining EyePoint Inc position as of Q1 2020 after selling out during the quarter.
Grimes & Company sold 9,850 EyePoint Inc shares in Q1 2020, an estimated $153K.
Grimes & Company first reported a position in EyePoint Inc in Q4 2019 and held it in 1 quarter.
Grimes & Company's EyePoint Inc position peaked at $153K in Q4 2019.
66 funds tracked by Wall St. Rank held EyePoint Inc as of Q1 2020.

Based on Grimes & Company's 13F filing for Q1 2020, filed 5 May 2020.